Disease associated variation - GWASdb Chr Pos SNP ID(dbSNP 142) Ref Alt Ori SNP ID P-value Drug Name Drug Anno GWAS Trait HPO ID DO ID AA Type Trait or Drug 20 31512285 rs41492345 G A rs41492345 3.53E-05 CISPLATIN|ETOPOSIDE|CARBOPLATIN R-SNARE PROTEINS|PLATINUM|STXBP5 PROTEIN, HUMAN|NERVE TISSUE PROTEINS Response to platinum-based chemotherapy in small-cell lung cancer HPOID:0100526 DOID:5409 G intron GWASdb_drug 20 31446858 rs8123073 A G rs8123073 5.00E-06 Attention deficit hyperactivity disorder (combined symptoms) HPOID:0007018 DOID:1094 A intron GWASdb_trait 20 31447368 rs17123726 A G rs17123726 5.00E-06 Attention deficit hyperactivity disorder (combined symptoms) HPOID:0007018 DOID:1094 A intron GWASdb_trait 20 31452956 rs17370071 C T rs17370071 7.21E-04 Type 2 diabetes HPOID:0005978 DOID:9352 C intron GWASdb_trait 20 31461082 rs2014837 T C rs2014837 2.50E-05 Urinary metabolites HPOID:0000079 DOID:557 C intron GWASdb_trait 20 31502332 rs6119304 A C rs6119304 7.16E-05 HIV-1 viral setpoint HPOID:0002721 DOID:526 G intron GWASdb_trait 20 31511702 rs11697967 A C rs11697967 6.80E-04 Alcohol dependence HPOID:0000707 DOID:0050741 A intron GWASdb_trait 20 31512285 rs41492345 G A rs41492345 3.53E-05 Response to platinum-based chemotherapy in small-cell lung cancer HPOID:0100526 DOID:5409 G intron GWASdb_trait 20 31531544 rs13045180 C T rs13045180 9.00E-06 Type 1 diabetes nephropathy HPOID:0100651 DOID:9744|DOID:2370 C STOP-GAIN GWASdb_trait